Physician profile
Akhil Khanna
NPI 1316915143
$2,059,032.33
in general payments reported to CMS, 2019-2025
15 companies · $508K in 2025
The $508K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98K · 2020: $143K · 2021: $239K · 2022: $300K · 2023: $440K · 2024: $330K · 2025: $508K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.2M · Acquisitions: $78K · Food and Beverage: $2,477 · Travel and Lodging: $1,185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,196,124.21 |
| Acquisitions | $78,450.84 |
| Food and Beverage | $2,476.64 |
| Travel and Lodging | $1,184.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $1,521,949.40 | 2020-2025 | Sable, Excelsiusgps Robotic Navigation System, Excelsius Gps |
| Orthofix Medical, INC. | $325,419.37 | 2019-2025 | Firebird Nxg, Physio-Stim |
| Ortho Development Corporation | $119,764.40 | 2019-2025 | |
| Zimmer Biomet Holdings, INC. | $78,508.27 | 2021-2023 | Archimis |
| Stryker Corporation | $8,865.76 | 2019-2025 | Serrato, Tritanium, Ozark Cervical Plate System |
| Medtronic USA, INC. | $2,540.46 | 2019 | |
| Nuvasive, INC. | $677.20 | 2021-2023 | Reline, Xlif, Attrax |
| Brainlab, INC. | $649.09 | 2019 | |
| Davol INC. | $193.65 | 2023 | |
| Medtronic, INC. | $146.80 | 2023 | Intellis Adaptivestim |
| Zimvie INC. | $115.97 | 2023 | |
| Abbott Laboratories | $102.96 | 2022 | |
| Medical Device Business Services, INC. | $99.00 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$101,911.15 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Akhil Khanna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.